RNA therapeutics: revolutionizing drug discovery
https://doi.org/10.4081/pcr.2023.9867
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
The astounding rate of advancement in the field of drug discovery and development is impossible to ignore.
A fresh and potent competitor to the conventional method of medication development, which mainly relies on small molecules, is RNA-based treatments. Among them, RNA Interference (RNAi) medicines and Messenger RNA (mRNA) vaccines have become the frontrunners, rewriting the rules for pre-clinical research and the creation of new treatments.
Fang E, Liu X, Li M, et al. Advances in COVID-19 mRNA vaccine development. Signal Transduct Target Ther 2022;7:94.
Pardi N, Hogan MJ, Porter FW, Weissman D. mRNA vaccines – a new era in vaccinology. Nat Rev Drug Discov 2018;17:261-79.
Smith ES, Whitty E, Yoo B, et al. Clinical applications of short noncoding RNA-based therapies in the era of precision medicine. Cancers 2022;14:1588.
Copyright (c) 2023 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Citations
